超全的新冠病毒突变蛋白试剂库-国内聚焦-资讯-生物在线
·

超全的新冠病毒突变蛋白试剂库

作者：北京义翘神州科技有限公司 2021-06-02T14:33 (访问量:10073)

重组Spike突变体N501Y

最近几个月，全球范围内分离出了多种新的新冠突变毒株。其中，U.K. variant B.1.1.7，the Brazil variant P.1，the South Africa variant B.1.351以及最新分离出的Indian variant B.1.617 具有很高的传染率，也因此备受关注。

在目前已经检测分离到的新冠突变株中，发生在Spike蛋白受体结合域的多个突变是主要的突变类型，也是最令人担心的突变。Spike蛋白受体结合域是新冠病毒结合宿主受体的主要结构，该结构的突变则有可能导致增强与受体的亲和力、减弱中和抗体效应或者造成病毒的免疫逃逸。

新冠突变株中同时存在N蛋白突变。N蛋白具有高度保守型，常被用作新冠抗原快速检测的标志物。目前已经上市的新冠抗原检测试剂是否可以检测到突变后的N蛋白以及检测灵敏度和特异性是否会受到突变的影响需要进一步的研究。

义翘神州开发了近150种新冠突变体蛋白，可用于抗体、疫苗等效力研究。

新冠突变体蛋白试剂库

B.1.617 (India*)

毒株 货号 抗原 突变位点 标签
B.1.617 40588-V07E16 N D377Y His
B.1.617 40588-V07E20 (under development) N R203M, D377Y His
B.1.617 40589-V08B12 (under development) S1+S2 ECD D614G, E154K, E484Q, E1072K, K1073R, L452R, P681R His
B.1.617 40589-V08B13 (under development) S1+S2 ECD D614G, E154K, E484Q, G142D, H1101D, L452R, P681R, Q1071H His
B.1.617 40591-V08H19 S1 D614G, E154K, E484Q, L452R, P681R His
B.1.617 40592-V08H28 RBD L452R His
B.1.617 40592-V08H81 RBD E484Q His
B.1.617/B.1.617.1/b.1.617.3 40592-V08H88 RBD L452R，E484Q His
B.1.617.2 40592-V08H90 (under development) RBD L452R,T478K His
B.1.617/B.1.617.1/b.1.617.3 40592-V02H2 (under development) RBD L452R，E484Q Fc
B.1.617.2 40592-V02H3 (under development) RBD L452R,T478K Fc
B.1.617.1 40589-V08B15 (under development) S1+S2 ECD T95I,G142D, E154K, L452R,E484Q, D614G, P681R,Q1071H His
B.1.617.2 40589-V08B16 (under development) S1+S2 ECD T19R, G142D, del157/158, L452R,T478K, D614G, P681R, D950N His
B.1.617.3 40589-V08B17 (under development) S1+S2 ECD T19R, L452R, E484Q,D614G, P681R, D950N，G142D His
B.1.617.1 40591-V08H22 (under development) S1 T95I,G142D, E154K, L452R,E484Q, D614G, P681R His
B.1.617.2 40591-V08H23 (under development) S1 T19R, G142D, E156G，del157/158, L452R,T478K, D614G, P681R His
B.1.617.3 40591-V08H24 (under development) S1 T19R, L452R, E484Q,D614G, P681R，G142D His

Epsilon | B.1.427/B.1.429 (U.S.A*)

毒株 货号 抗原 突变位点 标签
B.1.429/B.1.427 40591-V08H17 S1 W152C, L452R, D614G His
B.1.429/B.1.427 40588-V07E9 N T205I His

Alpha | B.1.1.7 (U.K.*)

毒株 货号 抗原 突变位点 标签
B.1.1.7 40588-V07E1 N R203K, G204R His
B.1.1.7 40588-V07E17 N E378Q His
B.1.1.7 40588-V07E4 N I292T His
B.1.1.7 40588-V07E7 N D3L, R203K, G204R, S235F His
B.1.1.7 40588-V07E8 N D3L, S235F His
B.1.1.7 40589-V08B6 S1+S2 ECD H69del, V70del, Y144del, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H His
B.1.1.7 40591-V08H12 S1 H69del, V70del, Y144del, N501Y, A570D, D614G, P681H His
B.1.1.7 40591-V08H12-B S1-Biotinylated H69del, V70del, Y144del, N501Y, A570D, D614G, P681H His
B.1.1.7 40591-V08H7 S1 HV69-70 deletion, N501Y, D614G His
B.1.1.7 40592-V02H1 RBD N501Y Fc
B.1.1.7 40592-V08H18 RBD S494P His
B.1.1.7 40592-V08H82 RBD N501Y His
B.1.1.7 40592-V08H82-B RBD-Biotinylated N501Y His
B.1.1.7 40592-V31H1 (under development) RBD N501Y rFc
B.1.1.7, B.1.237 40588-V07E3 N S194L His
B.1.1.7, B.1.351, A.2.2 40588-V07E2 N P13L His

Beta | B.1.351 (South Africa*)

毒株 货号 抗原 突变位点 标签
B.1.351 40588-V07E9 N T205I His
B.1.351 40589-V08B11 S1+S2 ECD D80A, L242del, A243del, L244del, R246I, E484K, K417N, N501Y, D614G, A701V His
B.1.351 40589-V08B7 S1+S2 ECD L18F, D80A, D215G, LAL242-244 deletion, R246I, K417N, E484K, N501Y, D614G, A701V His
B.1.351 40589-V08B7-B S1+S2-Biotinylated L18F, D80A, D215G, LAL242-244 deletion, R246I, K417N, E484K, N501Y, D614G, A701V His
B.1.351 40589-V08B9 S1+S2 ECD D80A, K417N, E484K, N501Y, D614G, A701V His
B.1.351 40591-V08H10 S1 K417N, E484K, N501Y, D614G His
B.1.351 40591-V08H13 S1 NTD L18F, D80A, D215G, LAL242-244 deletion, R246I His
B.1.351 40591-V08H15 S1 L18F, D80A, D215G, LAL242-244 deletion, R246I, K417N, E484K, N501Y, D614G His
B.1.351 40592-V08H59 RBD K417N His
B.1.351 40592-V08H59-B RBD-Biotinylated K417N His
B.1.351 40592-V08H84 RBD E484K His
B.1.351 40592-V08H84-B RBD-Biotinylated E484K His
B.1.351 40592-V08H85 RBD K417N, E484K, N501Y His
B.1.351 40592-V08H85-B RBD-Biotinylated K417N, E484K, N501Y His
B.1.351 40592-V02H4 (under development) RBD K417N, E484K, N501Y Fc
B.1.351 40592-V31H2 (under development) RBD E484K rFc
B.1.351 40592-V31H4 (under development) RBD K417N, E484K, N501Y rFc
B.1.351 40592-V31H6 (under development) RBD K417N rFc
B.1.351,B.1.427,B.1.429 40588-V07E24 (under development) N T205I,A220V,P13L His

Gamma | P.1 (Brazil*)

毒株 货号 抗原 突变位点 标签
P.1 40588-V07E11 N P80R His
P.1 40589-V08B10 (under development) S1+S2 ECD L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F His
P.1 40589-V08B8 S1+S2 ECD L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I His
P.1 40591-V08H14 S1 L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y His
P.1 40591-V08H5 S1 T20N, D614G His
P.1 40592-V08H86 RBD K417T, E484K, N501Y His
P.1 40592-V02H5 (under development) RBD K417T, E484K, N501Y Fc
P.1 40592-V31H5 (under development) RBD K417T, E484K, N501Y rFc
P.1 40592-V31H7 (under development) RBD K417T rFc

Mink Variant (Denmark*)

货号 抗原 突变位点 标签
40591-V08H8 S1 ΔH69/ΔV70, Y453F, D614G His
40592-V08H80 RBD Y453F His
40592-V31H3 (under development) RBD Y453F rFc

High Frequency Mutation of Nucleocapsid

毒株 货号 抗原 突变位点 标签
High Frequency N 40588-V07E1 N R203K, G204R His
High Frequency N 40588-V07E11 N P80R His
High Frequency N 40588-V07E2 N P13L His
High Frequency N 40588-V07E3 N S194L His
High Frequency N 40588-V07E4 N I292T His
High Frequency N 40588-V07E9 N T205I His

More Variants

,
货号 抗原 突变位点 标签
40589-V08B14 S1+S2 ECD Y145del, H146del, E484K, D614G His
40589-V08B4 S1+S2 ECD D614G His
40589-V08B5 S1+S2 ECD HV69-70 deletion, D614G, D796H His
40590-V02H1 S2 E780Q Fc
40591-V02H3 S1 D614G Fc
40591-V08H11 S1 N234Q His
40591-V08H16 S1 Q677H His
40591-V08H21 (under development) S1 H49Y, Y145del, H146del, E484K, D614G His
40591-V08H3 S1 D614G His
40591-V08H4 S1 A222V, D614G His
40591-V08H6 S1 L18F, D614G His
40591-V08H9 S1 HV69-70 deletion, N439K, D614G His
40592-V05H1 RBD V367F mFc
40592-V08H1 RBD V367F His
40592-V08H10 RBD R408I His
40592-V08H11 RBD V341I His
40592-V08H12 RBD Y508H His
40592-V08H14 RBD N439K His
40592-V08H15 RBD V503F His
40592-V08H16 RBD A522V His
40592-V08H19 RBD A372S His
40592-V08H2 RBD N354D His
40592-V08H20 RBD A520S His
40592-V08H21 RBD A522S His
40592-V08H22 RBD D405V, Q414A His
40592-V08H23 RBD Q414E His
40592-V08H24 RBD P384L His
40592-V08H25 RBD A348S His
40592-V08H26 RBD F338L His
40592-V08H27 RBD F377L His
40592-V08H29 RBD P521S His
40592-V08H30 RBD T478I His
40592-V08H31 RBD V483I His
40592-V08H32 RBD S359N His
40592-V08H33 RBD K378R His
40592-V08H34 RBD Q409E His
40592-V08H35 RBD I472V His
40592-V08H36 RBD A372T His
40592-V08H37 RBD A344S His
40592-V08H39 RBD A520V
北京义翘神州科技有限公司 商家主页

地 址： 北京亦庄东区科创十街18号院9号楼306室

联系人： 客服部

电 话： 400-890-9989

传 真： 010-50911666

Email：marketing@sinobiological.cn

相关咨询

义翘神州与镁伽达成深度战略合作，全自动质粒构建系统项目正式落地 (2023-04-20T08:30 浏览数:9756)

义翘神州年中促销活动正式开始啦 (2022-07-01T16:56 浏览数:10684)

义翘神州成功开发“奥密克戎”变异株重组蛋白 (2021-12-03T09:57 浏览数:9607)

第五届青科会广发“英雄令”，诚邀麒麟之才共襄科研赛事 (2021-09-16T14:51 浏览数:9886)

义翘神州成功上市，开启发展新征程 (2021-08-16T11:05 浏览数:16140)

可识别多种抗原的流感广谱抗体 (2021-08-02T10:05 浏览数:9991)

1000+重组病毒抗原库：ProVir (2021-06-25T15:41 浏览数:17314)

突变株不断出现，我们应该如何应对 (2021-06-02T14:46 浏览数:6647)

超全的新冠病毒突变蛋白试剂库 (2021-06-02T14:33 浏览数:10073)

2015-2022 流感疫苗株重组抗原 (2021-05-07T16:04 浏览数:15064)

ADVERTISEMENT